AAF-CMK
AAF-CMK is a TPPII (tripeptidylpeptidase II) inhibitor, shows anti-tumor activity and induces apoptosis. AAF-CMK can be used in leukemia research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 102129-66-8
- 화학식: C16H22ClN3O3
- 분자량:339.82
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
AAF-CMK (0-20 μM; 24 h) shows potentiated antitumor effects of U937 leukemia cells in combination with TRAIL or TNF[1].
AAF-CMK (20 μM; 24 h) increases TNF- and TRAIL-induced U937 cell apoptosis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:U937 human promonocytic leukemia cells
-
Concentration:0-20 μM
-
Incubation Time:24 h
-
Result:Resulted in the potentiation of growth inhibitory cytostatic effects of TRAIL as well as TNF.
-
Cell Line:U937 human promonocytic leukemia cells
-
Concentration:20 μM
-
Incubation Time:24 h
-
Result:Increased the percentage of apoptotic cells to 55.8% in combination with TRAIL.
Increased number of cells with characteristic apoptotic morphology in groups treated with AAF-CMK and both TRAIL or TNF compared to each group treated alone.
Chemical Information
-
CAS No. 102129-66-8
-
분자량 339.82
-
화학식 C16H22ClN3O3
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)